Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug Monitoring.
Saved in:
| Title: | Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug Monitoring. |
|---|---|
| Authors: | Sayadi H; Service of Pharmacology, Toxicology and Pharmacovigilance Department, CHU Dupuytren, Limoges, France., Fromage Y; Service of Pharmacology, Toxicology and Pharmacovigilance Department, CHU Dupuytren, Limoges, France., Monchaud C; Service of Pharmacology, Toxicology and Pharmacovigilance Department, CHU Dupuytren, Limoges, France.; Pharmacology & Transplantation, Inserm U1248, Univ. Limoges, CHU Dupuytren, Limoges, France ; and., Languepin J; CRCM Mixte Limousin, Department of Medical Pediatrics, CHU Dupuytren, Limoges, France ., Masson-Rouchaud A; CRCM Mixte Limousin, Department of Medical Pediatrics, CHU Dupuytren, Limoges, France ., Labriffe M; Service of Pharmacology, Toxicology and Pharmacovigilance Department, CHU Dupuytren, Limoges, France.; Pharmacology & Transplantation, Inserm U1248, Univ. Limoges, CHU Dupuytren, Limoges, France ; and., Woillard JB; Service of Pharmacology, Toxicology and Pharmacovigilance Department, CHU Dupuytren, Limoges, France.; Pharmacology & Transplantation, Inserm U1248, Univ. Limoges, CHU Dupuytren, Limoges, France ; and. |
| Source: | Therapeutic drug monitoring [Ther Drug Monit] 2025 Apr 01; Vol. 47 (2), pp. 189-192. Date of Electronic Publication: 2024 Nov 12. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39933065 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug Monitoring. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sayadi+H%22">Sayadi H</searchLink>; Service of Pharmacology, Toxicology and Pharmacovigilance Department, CHU Dupuytren, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Fromage+Y%22">Fromage Y</searchLink>; Service of Pharmacology, Toxicology and Pharmacovigilance Department, CHU Dupuytren, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Monchaud+C%22">Monchaud C</searchLink>; Service of Pharmacology, Toxicology and Pharmacovigilance Department, CHU Dupuytren, Limoges, France.; Pharmacology & Transplantation, Inserm U1248, Univ. Limoges, CHU Dupuytren, Limoges, France ; and.<br /><searchLink fieldCode="AU" term="%22Languepin+J%22">Languepin J</searchLink>; CRCM Mixte Limousin, Department of Medical Pediatrics, CHU Dupuytren, Limoges, France .<br /><searchLink fieldCode="AU" term="%22Masson-Rouchaud+A%22">Masson-Rouchaud A</searchLink>; CRCM Mixte Limousin, Department of Medical Pediatrics, CHU Dupuytren, Limoges, France .<br /><searchLink fieldCode="AU" term="%22Labriffe+M%22">Labriffe M</searchLink>; Service of Pharmacology, Toxicology and Pharmacovigilance Department, CHU Dupuytren, Limoges, France.; Pharmacology & Transplantation, Inserm U1248, Univ. Limoges, CHU Dupuytren, Limoges, France ; and.<br /><searchLink fieldCode="AU" term="%22Woillard+JB%22">Woillard JB</searchLink>; Service of Pharmacology, Toxicology and Pharmacovigilance Department, CHU Dupuytren, Limoges, France.; Pharmacology & Transplantation, Inserm U1248, Univ. Limoges, CHU Dupuytren, Limoges, France ; and. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227909660%22">Therapeutic drug monitoring</searchLink> [Ther Drug Monit] 2025 Apr 01; Vol. 47 (2), pp. 189-192. <i>Date of Electronic Publication: </i>2024 Nov 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Case Reports – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7909660 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1536-3694 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201634356%22">01634356 </searchLink><i>NLM ISO Abbreviation: </i>Ther Drug Monit <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39933065 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/FTD.0000000000001267 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 189 Titles: – TitleFull: Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug Monitoring. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sayadi H – PersonEntity: Name: NameFull: Fromage Y – PersonEntity: Name: NameFull: Monchaud C – PersonEntity: Name: NameFull: Languepin J – PersonEntity: Name: NameFull: Masson-Rouchaud A – PersonEntity: Name: NameFull: Labriffe M – PersonEntity: Name: NameFull: Woillard JB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2025 Apr 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1536-3694 Numbering: – Type: volume Value: 47 – Type: issue Value: 2 Titles: – TitleFull: Therapeutic drug monitoring Type: main |
| ResultId | 1 |
